Insight Biotechnology search:

<<First <Prev Next> Last>>

Search Results for:
Catalogue No	Partner	Description	Species	Application
HY-RI01265A-5nmol	MedChemexpress LLC	hsa-miR-4691-3p antagomir
HY-RI01265-20nmol	MedChemexpress LLC	hsa-miR-4691-3p inhibitor
HY-RI01265-5nmol	MedChemexpress LLC	hsa-miR-4691-3p inhibitor
HY-R01265-20nmol	MedChemexpress LLC	hsa-miR-4691-3p mimic		Cancer-programmed cell death
HY-R01265-5nmol	MedChemexpress LLC	hsa-miR-4691-3p mimic		Cancer-programmed cell death
HY-R01266A-20nmol	MedChemexpress LLC	hsa-miR-4691-5p agomir
HY-R01266A-5nmol	MedChemexpress LLC	hsa-miR-4691-5p agomir
HY-RI01266A-20nmol	MedChemexpress LLC	hsa-miR-4691-5p antagomir
HY-RI01266A-5nmol	MedChemexpress LLC	hsa-miR-4691-5p antagomir
HY-RI01266-20nmol	MedChemexpress LLC	hsa-miR-4691-5p inhibitor
HY-RI01266-5nmol	MedChemexpress LLC	hsa-miR-4691-5p inhibitor
HY-R01266-20nmol	MedChemexpress LLC	hsa-miR-4691-5p mimic		Cancer-programmed cell death
HY-R01266-5nmol	MedChemexpress LLC	hsa-miR-4691-5p mimic		Cancer-programmed cell death
HY-R01267A-20nmol	MedChemexpress LLC	hsa-miR-4692 agomir
HY-R01267A-5nmol	MedChemexpress LLC	hsa-miR-4692 agomir
HY-RI01267A-20nmol	MedChemexpress LLC	hsa-miR-4692 antagomir
HY-RI01267A-5nmol	MedChemexpress LLC	hsa-miR-4692 antagomir
HY-RI01267-20nmol	MedChemexpress LLC	hsa-miR-4692 inhibitor
HY-RI01267-5nmol	MedChemexpress LLC	hsa-miR-4692 inhibitor
HY-R01267-20nmol	MedChemexpress LLC	hsa-miR-4692 mimic		Cancer-programmed cell death
HY-R01267-5nmol	MedChemexpress LLC	hsa-miR-4692 mimic		Cancer-programmed cell death
HY-R01268A-20nmol	MedChemexpress LLC	hsa-miR-4693-3p agomir
HY-R01268A-5nmol	MedChemexpress LLC	hsa-miR-4693-3p agomir
HY-RI01268A-20nmol	MedChemexpress LLC	hsa-miR-4693-3p antagomir
HY-RI01268A-5nmol	MedChemexpress LLC	hsa-miR-4693-3p antagomir